Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00579007 · ClinicalTrials.gov registry record

Decision-making Regarding Prophylactic Mastectomy and Oophorectomy in Women Seeking Genetic Counseling and Testing for BRCA1/2 Mutations

A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
224
Enrollment target

NCT00579007: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT00579007 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 224 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00579007 has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
224 participants
Enrollment target

Study Summary

The purpose of this study is to learn more about women's decision to undergo prophylactic surgery. This is removal of healthy organs in order to reduce risk of cancer. This study will help us to understand what makes women decide whether or not to have this kind of surgery.

Interventions

  • BEHAVIORAL telephone interviews

Trial Details

FieldValue
Enrollment Target 224 participants
Start Date 2003-03-11
Est. Completion 2019-11-20

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT00579007

The ClinicalTrials.gov registry entry for NCT00579007 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 224 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which telephone interviews is the first listed.

NCT00579007 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00579007 about?

NCT00579007 is a clinical study titled "Decision-making Regarding Prophylactic Mastectomy and Oophorectomy in Women Seeking Genetic Counseling and Testing for BRCA1/2 Mutations". The purpose of this study is to learn more about women's decision to undergo prophylactic surgery. This is removal of healthy organs in order to reduce risk of cancer. This study will help us to understand what makes women decide whether or not to have this kind of surgery.

What is the current status of trial NCT00579007?

This trial is currently completed. The enrollment target is 224 participants. The study started on 2003-03-11. Estimated completion is 2019-11-20.

What interventions are being tested in trial NCT00579007?

The interventions under investigation include: telephone interviews (BEHAVIORAL).

Who is sponsoring clinical trial NCT00579007?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.